The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Serum amyloid α (SAA-1) SNP rs12218 to predict outcome for mCRC patients treated with FOLFIRI and bevacizumab: Data from FIRE-3 trial.
 
Martin D. Berger
No Relationships to Disclose
 
Sebastian Stintzing
Honoraria - Amgen; Merck KGaA; Roche/Genentech; Sanofi; Sirtex Medical
Consulting or Advisory Role - Amgen; Merck KGaA; Roche/Genentech
Travel, Accommodations, Expenses - Merck KGaA; Roche/Genentech
 
Volker Heinemann
Honoraria - Amgen; Bayer; Merck KGaA; Pfizer; Roche/Genentech; Sanofi
Consulting or Advisory Role - Amgen; Bayer; Merck KGaA; Roche; Sanofi
Research Funding - Amgen; Roche
 
Dongyun Yang
No Relationships to Disclose
 
Yu Sunakawa
Honoraria - Chugai Pharma; Daiichi Sankyo; Merck Serono; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Yan Ning
No Relationships to Disclose
 
Satoshi Matsusaka
No Relationships to Disclose
 
Satoshi Okazaki
No Relationships to Disclose
 
Yuji Miyamoto
No Relationships to Disclose
 
Mitsukuni Suenaga
No Relationships to Disclose
 
Jordan David West
No Relationships to Disclose
 
Wu Zhang
No Relationships to Disclose
 
Nicos Petasis
Leadership - C5Rx
Stock and Other Ownership Interests - BioMedix; C5Rx; RasRx; Resolvyx
Patents, Royalties, Other Intellectual Property - RasRx; Resolvyx; Viomedix
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; Celgene; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche